Quality Chemical Industries Limited (UGSE:QCIL)

Uganda flag Uganda · Delayed Price · Currency is UGX
0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Market Cap441.88B +55.1%
Revenue (ttm)263.07B -11.2%
Net Income42.47B -15.5%
EPS11.63 -15.7%
Shares Out3.65B
PE Ratio10.40
Forward PEn/a
Dividend14.20 (11.74%)
Ex-Dividend DateFeb 24, 2026
Volumen/a
Average Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Beta-0.12
RSI67.15
Earnings DateMay 8, 2026

About UGSE:QCIL

Quality Chemical Industries Limited manufactures and sells pharmaceutical drugs in Uganda. The company offers lamivudine/tenofovir disoproxil fumarate, dolutegravir, efavirenz, and zidovudine tablets for the treatment of HIV infection. It also provides lumartem/lumet tablets for the treatment of malaria; texavir and zentair for the treatment of Hepatitis B; and isoniazid/pyridoxine hydrochloride /sulfamethoxazole trimethoprim tablets for the treatment of tuberculosis. In addition, the company offers emeset for the treatment of nausea and vomiti... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 362
Stock Exchange Uganda Securities Exchange
Ticker Symbol QCIL
Full Company Profile

Financial Performance

In fiscal year 2025, UGSE:QCIL's revenue was 267.13 billion, an increase of 0.67% compared to the previous year's 265.34 billion. Earnings were 40.65 billion, an increase of 28.00%.

Financial Statements